A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successf ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes mellitus (T2D) and chronic kidney disease (CKD). The approval was based on data from the randomized, double-blind ...